Quanchi Chen

Quanchi Chen

Auto-generated profile, based on publicly available information

Quanchi Chen

Nanjing Univ, Affiliated Hosp, Nanjing Drum Tower Hosp, Div Spine Surg,Dept Orthoped Surg,Med Sch, Nanjing 210008, Peoples R China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2024 in Angiogenesis
Verified
Journal Article
Open access
PDF file
JYJie Yin
Jie Yin
Gabriel Forn-CuníGabriel Forn-Cuní
Gabriel Forn-Cuní
ASAkshaya Mahalakshmi Surendran
Akshaya Mahalakshmi Surendran
BBBruno Miguel Lopes Bastos
Bruno Miguel Lopes Bastos
NPNiki Pouliopoulou
Niki Pouliopoulou
ESEwa Snaar-Jagalska
Ewa Snaar-Jagalska
Conjunctival melanoma (CoM) is a rare but potentially lethal cancer of the eye, with limited therapeutic option for metastases. A better understanding how primary CoM disseminate to form metastases is urgently needed in order to develop novel therapies. Previous studies indicated that primary CoM tumors express Vascular Endothelial Growth Factor (VEGF) and may recruit pro-tumorigenic M2-like macrophages. However, due to a lack of proper models, the expected role of angiogenesis in the metastatic dissemination of CoM is still unknown. We show that cells derived from two CoM cell lines induce a strong angiogenic response when xenografted in zebrafish larvae. CoM cells are highly glycolytic and secrete lactate, which recruits and polarizes human and zebrafish macrophages towards a M2-like phenotype. These macrophages elevate the levels of proangiogenic factors such as VEGF, TGF-β, and IL-10 in the tumor microenvironment to induce an angiogenic response towards the engrafted CoM cells in vivo. Chemical ablation of zebrafish macrophages or inhibition of glycolysis in CoM cells terminates this response, suggesting that attraction of lactate-dependent macrophages into engrafted CoM cells drives angiogenesis and serves as a possible dissemination mechanism for glycolytic CoM cells.

16 May 2022 in Chemical Science
Verified
Journal Article
Open access
PDF file
QCQuanchi Chen
Quanchi Chen
JCJordi-Amat Cuello-Garibo
Jordi-Amat Cuello-Garibo
LBLudovic Bretin
Ludovic Bretin
LZLiyan Zhang
Liyan Zhang
VRVadde Ramu
Vadde Ramu
SBSylvestre Bonnet
Sylvestre Bonnet
In vivo data are rare but essential for establishing the clinical potential of ruthenium-based photoactivated chemotherapy (PACT) compounds, a new family of phototherapeutic drugs that are activated via ligand photosubstitution. Here a novel trisheteroleptic ruthenium complex [Ru(dpp)(bpy)(mtmp)](PF6)2 ([2](PF6)2, dpp = 4,7-diphenyl-1,10-phenanthroline, bpy = 2,2′-bipyridine, mtmp = 2-methylthiomethylpyridine) was synthesized and its light-activated anticancer properties were validated in cancer cell monolayers, 3D tumor spheroids, and in embryonic zebrafish cancer models. Upon green light irradiation, the non-toxic mtmp ligand is selectively cleaved off, thereby releasing a phototoxic ruthenium-based photoproduct capable notably of binding to nuclear DNA and triggering DNA damage and apoptosis within 24–48 h. In vitro, fifteen minutes of green light irradiation (21 mW cm−2, 19 J cm−2, 520 nm) were sufficient to generate high phototherapeutic indexes (PI) for this compound in a range of cancer cell lines including lung (A549), prostate (PC3Pro4), conjunctival melanoma (CRMM1, CRMM2, CM2005.1) and uveal melanoma (OMM1, OMM2.5, Mel270) cancer cell lines. The therapeutic potential of [2](PF6)2 was further evaluated in zebrafish embryo ectopic (PC3Pro4) or orthotopic (CRMM1, CRMM2) tumour models. The ectopic model consisted of red fluorescent PC3Pro4-mCherry cells injected intravenously (IV) into zebrafish, that formed perivascular metastatic lesions at the posterior ventral end of caudal hematopoietic tissue (CHT). By contrast, in the orthotopic model, CRMM1- and CRMM2-mCherry cells were injected behind the eye where they developed primary lesions. The maximally-tolerated dose (MTD) of [2](PF6)2 was first determined for three different modes of compound administration: (i) incubating the fish in prodrug-containing water (WA); (ii) injecting the prodrug intravenously (IV) into the fish; or (iii) injecting the prodrug retro-orbitally (RO) into the fish. To test the anticancer efficiency of [2](PF6)2, the embryos were treated 24 h after engraftment at the MTD. Optimally, four consecutive PACT treatments were performed on engrafted embryos using 60 min drug-to-light intervals and 90 min green light irradiation (21 mW cm−2, 114 J cm−2, 520 nm). Most importantly, this PACT protocol was not toxic to the zebrafish. In the ectopic prostate tumour models, where [2](PF6)2 showed the highest photoindex in vitro (PI > 31), the PACT treatment did not significantly diminish the growth of primary lesions, while in both conjunctival melanoma orthotopic tumour models, where [2](PF6)2 showed more modest photoindexes (PI ∼ 9), retro-orbitally administered PACT treatment significantly inhibited growth of the engrafted tumors. Overall, this study represents the first demonstration in zebrafish cancer models of the clinical potential of ruthenium-based PACT, here against conjunctival melanoma.

17 January 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
WLWenhan Li
Wenhan Li
HSHaiwen Su
Haiwen Su
YMYanyu Ma
Yanyu Ma
HRHaoyu Ren
Haoyu Ren
ZFZhenhua Feng
Zhenhua Feng
ZZZezhang Zhu
Zezhang Zhu

10 July 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
YMYanyu Ma
Yanyu Ma
HSHaiwen Su
Haiwen Su
WLWenhan Li
Wenhan Li
SMSaihu Mao
Saihu Mao
ZFZhenghua Feng
Zhenghua Feng
ZZZezhang Zhu
Zezhang Zhu

30 November 2024 in Chemical Engineering Journal
Verified
Journal Article
Closed access
HSHaiwen Su
Haiwen Su
YMYanyu Ma
Yanyu Ma
WLWenhan Li
Wenhan Li
HRHaoyu Ren
Haoyu Ren
XMXiayidan Maimaitikelimu
Xiayidan Maimaitikelimu
HWHuan Wang
Huan Wang

1 March 2023 in Engineered Regeneration
Verified
Journal Article
Open access
YMYanyu Ma
Yanyu Ma
QCQuanchi Chen
Quanchi Chen
WLWenhan Li
Wenhan Li
HSHaiwen Su
Haiwen Su
SLSong Li
Song Li
ZZZezhang Zhu
Zezhang Zhu